In a regulatory filing, the company said the sale is part of its strategy to monetise non-core assets, adding the proceeds will strengthen its balance sheet. The transaction is subject to Shriram Ownership Trust obtaining regulatory approvals and expected to be completed by March 31
In a regulatory filing, the company said the sale is part of its strategy to monetise non-core assets, adding the proceeds will strengthen its balance sheet. The transaction is subject to Shriram Ownership Trust obtaining regulatory approvals and expected to be completed by March 31